HIGHLIGHTS
- who: Xiao-Ping Li et al. from the Department of Thoracic Surgery, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China have published the research: Effectiveness and Safety of PD-1 Inhibitor Monotherapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Exploratory Study, in the Journal: Journal of Oncology of 22/07/2022
- what: All the data involved in the study were statistically carried out using SPSS (version 25.0). This study provided real-world evidence regarding the feasibility and tolerability regarding the administration of PD-1 inhibitor . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.